Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Analysis of leukocyte transepithelial migration using an in vivo murine colonic loop model
Sven Flemming, … , Asma Nusrat, Charles A. Parkos
Sven Flemming, … , Asma Nusrat, Charles A. Parkos
Published October 18, 2018
Citation Information: JCI Insight. 2018;3(20):e99722. https://doi.org/10.1172/jci.insight.99722.
View: Text | PDF
Resource and Technical Advance Gastroenterology Inflammation

Analysis of leukocyte transepithelial migration using an in vivo murine colonic loop model

  • Text
  • PDF
Abstract

Molecular mechanisms that control leukocyte migration across the vascular endothelium (transendothelial migration; TEndoM) have been extensively characterized in vivo, but details of leukocyte transepithelial migration (TEpM) and its dysregulation (a pathologic feature of many mucosal diseases) are missing due to the lack of suitable animal models. Here, we describe a murine model that utilizes a vascularized proximal colonic segment (pcLoop) and enables quantitative studies of leukocyte trafficking across colonic epithelium. Consistent with previous in vitro studies, intraluminal injection of antibodies against integrin CD11b/CD18 reduced recruitment of polymorphonuclear neutrophils (PMN) into the lumen of pcLoops, and it increased subepithelial accumulation of PMN. We extended studies using the pcLoop to determine contributions of Junctional Adhesion Molecule-A (JAM-A, or F11R) in PMN TEpM and confirmed that mice with total loss of JAM-A or mice with intestinal epithelial selective loss of JAM-A had increased colonic permeability. Furthermore, there was reduced PMN migration into the colonic lumen that paralleled subepithelial accumulation of PMN in global-KO mice, as well as in intestinal epithelial-targeted JAM-A–deficient mice. These findings highlight a potentially novel role for JAM-A in regulating PMN TEpM in vivo and demonstrate utility of this model for identifying receptors that may be targeted in vivo to reduce pathologic intestinal inflammation.

Authors

Sven Flemming, Anny-Claude Luissint, Asma Nusrat, Charles A. Parkos

×

Figure 5

Selective loss of JAM-A on intestinal epithelial cells results in increased epithelial permeability and decreased PMN TEpM.

Options: View larger image (or click on image) Download as PowerPoint
Selective loss of JAM-A on intestinal epithelial cells results in increa...
(A) Immunofluorescence staining showing selective loss of JAM-A (green) on intestinal epithelial cells in Villin-cre; Jam-afl/fl mice compared with control Jam-afl/fl mice. JAM-A is still present in the lamina propria compartment (arrows) including endothelial cells and leukocytes. Cell nuclei (Hoechst; blue). Asterisk represents intestinal lumen. Scale bars: 100 μm. (B) Permeability assay to 4 kDa FITC dextran (1 mg/ml) showed significantly increased intestinal paracellular permeability in Villin-cre; Jam-afl/fl (18 mice; black circles) compared with control (Jam-afl/fl, white circles: 12 mice). Data are means ± SEM; n = 4 independent experiments. ****P ≤ 0.0001; Mann–Whitney U test. (C) Number of PMN present in the lamina propria–enriched fraction of a segment of proximal colon (similar to pcLoop) under basal conditions (no surgery) in Jam-afl/fl mice (10 mice; white circles) and Villin-cre; Jam-afl/fl mice (14 mice; black circles). Data are means ± SEM; n = 3 independent experiments. **P < 0.01; 2-tailed Student’s t test. (D) Number of PMN in the pcLoop lumen in response to 1 nM LTB4 in Villin-cre; Jam-afl/fl mice (11 mice; black circles) and Jam-afl/fl mice (10 mice; white circles). Data are means ± SEM; n = 3 independent experiments. *P < 0.05; 2-tailed Student’s t test. (E) Number of PMN in the lamina propria and epithelium fractions in pcLoop in control Jam-afl/fl (white circles) and Villin-cre; Jam-afl/fl mice (black circles). Epithelium-enriched fraction: Jam-afl/fl (6 mice) and Villin-cre; Jam-afl/fl mice (11 mice). Lamina propria–enriched fraction: Jam-afl/fl (6 mice) and Villin-cre; Jam-afl/fl mice (10 mice). Data are means ± SEM; n = 2 independent experiments. *P < 0.05; 1-way ANOVA followed by Bonferroni’s post-hoc multiple comparison tests.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts